Ana Laura Dias

Ana Laura Dias

Auto-generated profile, based on publicly available information

Ana Laura Dias

Research Institute for Medicines (iMed), Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
LBLibby Brown
Libby Brown
AVAldrin Vasco Vidal
Aldrin Vasco Vidal
ADAna Laura Dias
Ana Laura Dias
TRTiago Rodrigues
Tiago Rodrigues
ASAnna Sigurdardottir
Anna Sigurdardottir
GBGonçalo J. L. Bernardes
Gonçalo J. L. Bernardes
Cyclization provides a general strategy for improving the proteolytic stability, cell membrane permeability and target binding affinity of peptides. Insertion of a stable, non-reducible linker into a disulphide bond is a commonly used approach for cyclizing phage-displayed peptides. However, among the vast collection of cysteine reactive linkers available, few provide the selectivity required to target specific cysteine residues within the peptide in the phage display system, whilst sparing those on the phage capsid. Here, we report the development of a cyclopropenone-based proximity-driven chemical linker that can efficiently cyclize synthetic peptides and peptides fused to a phage-coat protein, and cyclize phage-displayed peptides in a site-specific manner, with no disruption to phage infectivity. Our cyclization strategy enables the construction of stable, highly diverse phage display libraries. These libraries can be used for the selection of high-affinity cyclic peptide binders, as exemplified through model selections on streptavidin and the therapeutic target αvβ3.

13 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ADAna Laura Dias
Ana Laura Dias
LBLatimah Bustillo
Latimah Bustillo
TRTiago Rodrigues
Tiago Rodrigues
Representation learning is making inroads into drug discovery. A study in Nature Communications emphasizes multiple limitations in property prediction. The results suggest that continued research and improvements are required for this specific area that coalesces machine learning and molecular medicine. Machine learning is a powerful tool for the study and design of molecules. Here the authors comment a recent publication in Nature Communications which highlights the challenges of different molecular representations for data-driven property predictions.

8 September 2025 in Nature Machine Intelligence
Verified
Journal Article
Closed access
PDF file
ADAna Laura Dias
Ana Laura Dias
TRTiago Rodrigues
Tiago Rodrigues